Nuance Communications, Inc. NUAN
We take great care to ensure that the data presented and summarized in this overview for Nuance Communications, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in NUAN
Top Purchases
Top Sells
About NUAN
Nuance Communications, Inc. provides conversational and cognitive artificial intelligence (AI) innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people - amplifying human intelligence to increase productivity and security. Its Healthcare segment provides clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Its solutions include Dragon Medical One, cloud-based speech solution; computer-assisted physician documentation; diagnostic imaging solutions; Nuance Dragon Ambient eXperience, a voice-enabled solution; and clinical documentation improvement and coding. The company's Enterprise segment primarily engages in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web, and messaging channels. Its solutions include intelligent engagement solutions; Conversational AI; Engagement AI; and Security AI. Its Other segment provides voicemail transcription services. It serves organizations across healthcare, financial services, telecommunications, government, and retail. The company markets and sells its solutions and technologies directly through sales force, as well as through a network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, telecommunications carriers, and e-commerce Websites worldwide. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was incorporated in 1992 and is headquartered in Burlington, Massachusetts. As of March 4, 2022, Nuance Communications, Inc. operates as a subsidiary of Microsoft Corporation.
Insider Transactions at NUAN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2022
|
Lloyd Carney Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,519
-100.0%
|
-
|
Mar 04
2022
|
Mark D Benjamin Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,209,427
-100.0%
|
-
|
Mar 04
2022
|
Mark D Benjamin Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
906,000
+50.0%
|
-
|
Mar 04
2022
|
Robert Weideman EVP & GM, Enterprise Division |
SELL
Sale (or disposition) back to the issuer
|
Direct |
325,225
-99.76%
|
-
|
Mar 04
2022
|
Robert Weideman EVP & GM, Enterprise Division |
BUY
Grant, award, or other acquisition
|
Direct |
227,534
+50.0%
|
-
|
Mar 04
2022
|
Wendy Cassity EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
239,329
-78.69%
|
-
|
Mar 04
2022
|
Wendy Cassity EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,489
+50.0%
|
-
|
Mar 04
2022
|
Joseph Carl Petro EVP & Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
348,317
-97.38%
|
-
|
Mar 04
2022
|
Joseph Carl Petro EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
228,669
+50.0%
|
-
|
Mar 04
2022
|
Robert J Finocchio Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
131,167
-51.72%
|
-
|
Mar 04
2022
|
Thomas D Ebling Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,011
-53.89%
|
-
|
Mar 04
2022
|
Diana L Nole EVP & GM, Healthcare Division |
SELL
Sale (or disposition) back to the issuer
|
Direct |
175,797
-100.0%
|
-
|
Mar 04
2022
|
Diana L Nole EVP & GM, Healthcare Division |
BUY
Grant, award, or other acquisition
|
Direct |
56,461
+50.0%
|
-
|
Mar 04
2022
|
Mark R Laret Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
85,667
-52.64%
|
-
|
Mar 04
2022
|
Daniel J. Brennan Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,011
-53.89%
|
-
|
Mar 04
2022
|
Laura S. Kaiser Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
74,356
-53.04%
|
-
|
Mar 04
2022
|
Daniel David Tempesta EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
360,767
-98.85%
|
-
|
Mar 04
2022
|
Daniel David Tempesta EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,287
+50.0%
|
-
|
Mar 04
2022
|
Michal Katz Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
58,011
-53.89%
|
-
|
Mar 04
2022
|
Sanjay Vaswani Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,174
-60.67%
|
-
|